Introduction {#sec1-1}
============

The memory demands for school age children are much greater than they are for adults and are continuously fed with new knowledge in various areas, which might be interesting or not to them. Moreover, children are expected to learn and remember them and repeat it during exams. Except when there is a marked deviation from the normal, young children are not aware of what their intellectual level is. The bright, for example, do not realize how bright they are, the dull are unaware of their dullness, and the average take their intelligence for granted. After they enter the school, children measure their level of intellectual power by the kind of adjustment they make to school work.\[[@ref1]\]

Intelligence may be narrowly defined as the capacity to acquire knowledge and understanding, and used in different novel situations. It is this ability, or capacity, which enables the individual to deal with real situations and profit intellectually from sensory experience. Although it is difficult to define intelligence, indeed it appears to have no formal definition, there is, nevertheless, at least one particularly apposite definition: The capacity to learn and understand.\[[@ref2]\]

In the Ayurvedic classics, the word "*Buddhi*" is used in many contexts. On studying it\'s literally meaning, (*Nirukti* and *Vyutpatti*) it can be understood as the psychological faculty for reasoning and logic. However, after critical analysis of classics, it is evident that at many places it has been used as an advance stage or as a process leading to a true knowledge. *Buddhi* is described as *Jnana* (knowledge).\[[@ref3]\] The word "*Medha*" has been used mainly in two ways viz. *Grahana Shakti* (grasping power) and *Dharana Shakti* (retention power).\[[@ref4]\] Besides this, *Buddhi*, *Smriti*, *Dhi*, etc., words have been used in a similar sense at many places.

Concept of improving cognitive functions like intelligence and memory is relatively very new to current modern system of medicine. The first drug discovered to enhance cognitive functions known as "Nootropics" were in 1972.\[[@ref5]\] Knowledge of natural herbal drugs possessing cognitive enhancing activity dates back to thousands of century back. "*Medhya Rasayana*" is a specific group of four, time-tested classical preparations for promotion of mental health and well-being.\[[@ref6]\] *Yashtimadhu* (*Glycyrrhiza glabra* Linn.) is one among them mentioned for these purpose by *Acharya* Charaka.\[[@ref6]\]

Abundant works have been carried out on varied systemic actions of *Yashtimadhu* in different disorders. Despite its mentioning as a potent *Medhya Dravya* by ancient scholars, only a fewer works have been carried out on the same until date. In this regard, Ayurveda has a potential to make a significant contribution with a potent and cost-effective *Medhya Dravya*.

There are a number of different methods, which contend to measure intelligence, the most famous of which is the intelligence quotient (IQ), or IQ test.\[[@ref1]\] The IQ is a score derived from one of several standardized tests designed carefully to assess intelligence. The method of testing *Medha* is explained as "*Grahanenaiti Granthadi Dharanena*"\[[@ref4]\] that is, understanding the ability of the person to understand, grasp, remember, and recall the *Granthas* (books) after reading.

By considering the above facts, this study has been undertaken to assess the efficacy of *Yashtimadhu* in enhancement of IQ in school going children.

Materials and Methods {#sec1-2}
=====================

Healthy school going children of 9^th^ and 10^th^ standard (aged 14--16 years) of either sex irrespective caste, religion, and socioeconomic status were duly registered in the outpatient department of *Kaumarabhritya* Department. The study was started after obtaining the consent of the patients. The written consent was detailed in the local language and explained orally too regarding the type and course of study. The clinical study was started after the approval of Institutional Ethics Committee (No. PGT/7-A/Ethics/2010--2011/3381) and the research work has been registered in Clinical Trial Registry of India (CTRI)-CTRI/2011/11/002136 (Registered on: 16/11/2011)-retrospectively. It is a randomized (random number table method), placebo-controlled clinical study.

Inclusion criteria {#sec2-1}
------------------

Children of 9^th^ and 10^th^ standard (aged 14--16 years) with IQ score ranging 70--109 (Scores obtained after conducting verbal and performance subtests) were included.

Exclusion criteria {#sec2-2}
------------------

Children suffering from any systemic disorders, which may turn out to be hindrance in the study

Grouping and posology {#sec2-3}
---------------------

The subjects included in the clinical trial were be divided into two groups namely,

Group A (Trial group) -- *Yashtimadhu* granules in the dose of 12g per day with luke warm milk\[[@ref6][@ref7]\]Group B (Placebo controlled group) --Wheat flour in the form of granules in the dose of 12g per day with luke warm milk.

In both the groups drugs were administered in *Apana Kala* (before breakfast) for 12 weeks. Follow up study was conducted after 12 weeks of completion of treatment. Test drugs were prepared and procured from - Pharmacy, Gujarat Ayurved University, Jamnagar.

Laboratory investigation {#sec2-4}
------------------------

Routine hematological, biochemical, urine, stool (routine and microscopic) investigations were carried to rule out any other pathological condition.

Assessment criteria {#sec2-5}
-------------------

Effect of therapy was assessed by using following parameters-

### A. Functional aspects of Buddhi {#sec3-1}

*Medham Grahanena* ScoreCan grasp the event at an instance, no confusional status 3Can grasp the event at an instance but gets confused 2Delayed grasping with frequent confusion 1Grasping and understanding is difficult with lack of confusion 0Smritim SmaranenaBoth remote and recent memory are clear with easy retention and recall 3Both remote and recent memory clear but retention and recall are not seen 2Remote memory is impaired but recent memory is intact. Power of retention and recall not seen 1Both remote and recent memory are impaired With difficult retention and recall 0Dhriti AlaulyenaCourageous on all occasions 3Courageous if supports are there 2Occasionally courageous if strong support is there 1No change at all 0Vijnana VyavasayenaSelf efficient and sufficient to direct and do various activities himself 3Self efficient and sufficient to direct and do various activities with help of others 2Not self efficient and sufficient, guidance required in each and every work 1Cannot do or direct any activity with loss of insight 0

### B. WHO quality of life parameters {#sec3-2}

Quality of life was assessed as per WHO guidelines.\[[@ref8]\]

### C. Rogi Bala (general health condition) {#sec3-3}

I. Agnibala

*Abhyavaharana Shakti (capacity to ingest)*: ScoreHaving food in good quantity twice/thrice 6Having food in normal quantity twice a day 5Having food in moderate quantity twice a day 4Having food in less quantity twice a day 3Having food in less quantity once in a day 2Not at all having food 1*Jarana Shakti* (capacity to digest):Scoring according to *Jeerna Ahara Lakshaana* present after 6-8 hrs after having food; *Utsaha*, *Laghuta*, *Udgarashuddhi*, *Kshut Trishna Pravritti*, *Yathochita Malotsarga*.*Jarana Shakti*: ScoreAbsence of any symptom 1Presence of one symptom 2Presence of any two symptoms 3Presence of any three symptoms 4Presence of any four symptoms 5Presence of five symptoms 6*Ruchi Aharakale* (capacity to relish taste while eating):Totally unwilling for meals 1Unwilling towards food but could take the meal 2Willing towards only most liking foods and not others 3Willing towards only one among *Katu/Amla/Madhura* foodstuffs 4Willing towards some specific *Ahara/Rasavishesha* 5Equally willing towards all the *Bhojya Padartha* 6*Vata Mutra Retasam Mukti* (frequency of bowel and urine evacuation):Passes stool after 3-4 days with *Grathitha*, *Sakashta Malapravritti* and having gaseous distension with Udgarapravritti 1Passes stool after 2-3 days having gaseous distension 2Can't pass stool daily and feeling heaviness in abdomen 3Difficulty in defecation, but daily with discomfort in abdomen 4Occurs easily in normal routine times 5

II\. Dehabala

1\. *Balavriddhi* (capacity for work):No weakness 1Slight weakness 2Feeling weakness but ability to work unaffected 3Ability to work affected 4Can't do any type of work 5*Swara Varna Yoga* (accession of voice and complexion):Patient looks cheerful 1Lethargic and tired 2Looks gloomy 3*Sharira Upachaya* (accession of body weight):No change 1Increase in weight by 2 kg 2Increase in weight by more than 2 kg 3

III\. Satva / Chetas Bala

*Nidra Labho Yathakalam* (status of sleep):No sleep in day or night 1Disturbed sleep in night and tries to compensate in day 2Sleeps with disturbed intervals and remains unsatisfied 3Sleep gets disturbed in early morning 4Sound sleep 5*Sukhena Cha Pratibodhanam* (feeling of well being):Not feeling well and not interested in any work 1Improved in physical and mental level 2Improved in physical comfort level 3Total relief and feeling of well being at physical and mental level 4*Vaikarikanam Cha Swapnanam Adarshanam* (absence of discomforting dreams):Daily 1Occasionally 2Absent 3*Mano Buddhi Indriya Avyapatti* (clarity of mind, intellect and sense organs):Loss of enthusiasm, concentration and vigour 1Less enthusiastic and not interested in routine work 2Less enthusiastic and not concentrating but interested in routine work 3Enthusiastic, vigorous, having concentration and interest in routine work 4

### D. Intelligence quotient {#sec3-4}

Clinical response to medication was assessed based upon the objective parameter IQ (IQ test performance which was done before and after treatment). Scores obtained in each item from the score table of IQ subtests that is, verbal and performance scales were considered as the individual criteria.\[[@ref8]\]

### Assessment of total effect of therapy {#sec3-5}

The improvement in functional aspects of *Buddhi*, IQ scores, quality of life (QoL) parameters was considered in the final assessment along with the improvement in the general health condition viz. *Dosha*, *Agni* and *Bala* of the children.

Statistical analysis {#sec2-6}
--------------------

Student '*t*' - test was the statistical tool used to assess and compare the efficacy of treatment.

Observations {#sec1-3}
============

In this study, a total of 94 children were registered based on inclusion criteria. Fifty-one in Group A and forty three in Group B. Out of them forty in Group A and thirty five in Group B completed the treatment.

Males represented 43.15%, and females were 56.85% with a mean IQ score of 88.04 and 89.8 respectively. About 28.33% of children in the trial were aged between 15 and 16 years and had a comparatively higher mean of IQ score of 91.57 then other aged children. There were 4.35% of children belonging to upper socioeconomic status with a comparatively higher mean of IQ score 99.5 than their compatriots. About 10.5% of children were studying in private English medium school with a comparatively higher mean IQ score of 95.93%. Among these, 3.1% of children\'s father and mother were educated till master degree and had a higher mean IQ score of 102.4 and 95.27 respectively.

Results {#sec1-4}
=======

Efficacy on functional aspects of *Buddhi* {#sec2-7}
------------------------------------------

On comparing, the efficacy of trial drug and placebo drug over the functional aspects of *Buddhi*, trial drug *Yashtimadhu* granules showed statistically highly significant changes in increasing *Medha* (*P* \< 0.0001), *Smriti* (*P* \< 0.0005), *Dhriti* (*P* \< 0.05) and *Vijnana* (*P* \< 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Comparative efficacy of *Yashtimadhu* and placebo granules on functional aspects of *Buddhi*

![](AYU-36-56-g001)

Efficacy on WHO quality of life parameter {#sec2-8}
-----------------------------------------

On comparing, the efficacy of trial drug and placebo drug over the WHO QOL parameter, *Yashtimadhu* granules showed statistically significant changes in improving physical health (*P* \< 0.05) and highly significant results in improving psychological health (*P* \< 0.001) on all other parameters, there were no significant changes between the two groups \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparative efficacy of *Yashtimadhu* and placebo granules on WHO QoL parameter

![](AYU-36-56-g002)

Efficacy on general health condition {#sec2-9}
------------------------------------

On comparing, the efficacy of trial drug and placebo drug on parameters of general health condition, trial drug provided statistically significant improvement by increasing *Bala*, *Swara*, *Varna* (complexion), *Nidra*, *Sukhena Cha Pratibodhanam*, and *Mano Buddhi Indriya Avyapatti* (*P* \< 0.05). On all other parameters, there were no significant changes noted between the drugs \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparative efficacy of *Yashtimadhu* and placebo granules on general health parameters

![](AYU-36-56-g003)

Efficacy on intelligence quotient {#sec2-10}
---------------------------------

On comparing the efficacy of trial drug and placebo drug over IQ, the trial drug *Yashtimadhu* granules provided statistically significant results in improving verbal IQ (*P* \< 0.05) and statistically highly significant results in improving performance and full score IQ (*P* \< 0.0005) \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparative efficacy of *Yashtimadhu* and placebo granules on intelligence quotient (IQ)

![](AYU-36-56-g004)

Overall outcome of therapy on intelligence quotient {#sec2-11}
---------------------------------------------------

In Group A, before treatment 42.5% and 57.5% of children belonged to dull IQ (70--89) and average IQ (90--109) category respectively, whereas after treatment 2.5% and 77.5% of children belonged to dull and average IQ category respectively. There were no children with superior IQ (110--124) category before treatment, whereas after treatment 20% of children belonged to superior IQ category \[[Figure 1](#F1){ref-type="fig"}\].

![Overall effect of therapy on intelligent quotient in Group A](AYU-36-56-g005){#F1}

In Group B, before treatment 62.8% and 37.2% of children belonged to dull IQ and average IQ category respectively, whereas after treatment 31.4% and 62.8% of children belonged to dull and average IQ category respectively. There were no children with superior IQ category before treatment, whereas after treatment 5.8% of children belonged to superior IQ category \[[Figure 2](#F2){ref-type="fig"}\].

![Overall effect of therapy on intelligent quotient in Group B](AYU-36-56-g006){#F2}

Evidence-based analysis {#sec2-12}
-----------------------

The number needed to treat (NNT) to achieve the target of IQ score minimum 90 and above was 3.38, which suggested that 1 out of every 3.38 children who were administered with *Yashtimadhu* granules achieved IQ score of 90 and above, which was statistically highly significant (*P* \< 0.005). The odd\'s ratio for achieving this target was 17.88.

The NNT to achieve the target of IQ score minimum 110 and above was 6.66. This suggests that one out of every 6.66 children achieved IQ score of 110 and above after administering *Yashtimadhu* granules which was statistically insignificant (*P* \> 0.05). The odd\'s ratio for achieving this target was 4.16 \[[Table 5](#T5){ref-type="table"}\].

###### 

Number need to treat (NNT)

![](AYU-36-56-g007)

Discussion {#sec1-5}
==========

Individuals differ from one another in their ability to understand complex ideas, to adapt effectively to the environment, to learn from experience, to engage in various forms of reasoning and to overcome obstacles by their thoughts. Although these individual differences can be substantial, they are never entirely consistent: A given person\'s intellectual performance will vary in different occasions, and in different domains, as judged by different criteria. Concepts of "intelligence" are attempts to clarify and organize this complex set of phenomena. Although considerable clarity has been achieved in some areas, no such conceptualization has yet answered all the important questions and none commands universal assent.\[[@ref9]\]

To assess intelligence level of a child, many factors come into play such as his family background, social background, cultural background, scholastic background, mental status of the child during the testing procedure, environment where the test is conducted, the abilities and disabilities of the child in understanding the commands, etc.\[[@ref10]\] Therefore, one such test was necessary that would give an appropriate measure of IQ overcoming all the above differences and variations. By considering all the above factors Indian adaptation of Wechsler\'s intelligence scale for children -- Malin\'s intelligence scale for Indian children was selected, which has been constructed carefully suiting the standards of Indian children after scientific standardization of samples test items and establishments of the norms.\[[@ref8]\]

*Medha* is understood by *Grahana* and *Dharana Shakti* (grasping and retention power), *Smriti* by *Smarana Shakti* (recalling power), *Dhriti* by *Aloulyata* (absence of distraction) and *Vijnana* (nature and capacity to perform task alone).\[[@ref4]\] Hence, improvement in these functional aspects of *Buddhi* suggests improvement in the factors analyzed by them.

The factors used to analyze them where IQ test used in the study, which consisted of five verbal and five performance subtests. Verbal IQ tests measured general knowledge, factual knowledge, long-term memory, social -- practical judgment, short-term auditory memory, concentration, and numerical reasoning.\[[@ref8]\] Whereas performance IQ measured attention power, alertness to visual details and visual discrimination, visual-motor skills, coordination, short-term visual memory, nonverbal intelligence, spatial analysis, graphomotor planning, fine visual-motor coordination.\[[@ref8]\]

Based on the entities measured by IQ test and improvement in IQ score, it was understood that improvement in general knowledge, factual knowledge, and numerical reasoning as improvement in *Grahana* and *Dharana Shakti*, improvement in long-term memory, short term auditory memory and short term visual memory as improvement in *Smriti*, improvement in concentration, attention power, alertness to visual details and visual discrimination and fine visual-motor coordination as improvement in *Dhriti*, improvement in nonverbal intelligence, spatial analysis, graphomotor planning, along with general knowledge, factual knowledge as improvement in *Vijnana*.

The factors measured by these IQ subtests can be related with assessment of *Medha*, *Smriti*, *Dhriti* and *Vijnana* mentioned by Acharya Charaka\[[@ref4]\] in many ways, hence improvement in these factors was considered as functional increase of *Medha*, *Smriti*, *Dhriti* and *Vijnana*.

Improvements in physical (*P* \< 0.05) and psychological health (*P* \< 0.001) parameters of World Health Organization-QOL BREF suggest that the trial drug by the virtue of its *Balya* (promoters of strength), *Bruhmana* (roborant) and *Rasayana Karma* (rejuvenation) might have brought in these changes.

The improvement in the parameters of general health parameters can be attributed to the properties of the drug itself.\[[@ref11]\]

The mode of action of *Yashtimadhu* in improving *Medha* and IQ can be explained through pharmacodynamic properties and chemical constituents present in it. *Prabhava* (un explainable action) of *Yashtimadhu* brings about *Medhya* actions. "*Sadindriya Prasadaniya*" *Karma* of *Madhura Rasa* (sweet taste)\[[@ref11]\] present in *Yashtimadhu* nourishes *Manas* and *Buddhi*. *Snigdha Guna* (unctuous property) *Madhura Rasa* and *Madhura Vipaka* properties of *Yashtimadhu*\[[@ref11]\] regulate the *Chala Guna* (moveable property) of *Vata* and thereby influence the functions of *Manas* and *Buddhi*. Glycyrrhizin is generally regarded as the active principle of *G. glabra* and is responsible for its sweetness, which is 50 times that of sucrose,\[[@ref12]\] it thereby increases the bioavailability of glucose at brain level and thereby enhancing the activity of brain.\[[@ref13]\] Presence of flavonoids which are potent antioxidants plays a vital role in preventing oxidative damage to the brain and thereby enhancing the functions of brain.\[[@ref14]\] It also possesses acetyl cholinesterase inhibitory activity, which enhances the action and duration of neurotransmitter acetylcholine in central cholinergic pathways, which plays a prominent role in the learning and memory processes.\[[@ref15]\]

Conclusion {#sec1-6}
==========

Intelligence is a vital essentiality in day-to-day life, especially in children. *Medha*, *Smriti*, *Dhriti* and *Vijnana* can be considered as the functional aspects of *Buddhi*, and are interrelated with each other and are responsible for acquiring, storing and recalling knowledge. Entities measured by verbal and performance IQ scale had similarity to those mentioned for assessing *Medha*, *Smriti*, *Dhriti* and *Vijnana* by Acharya Charaka, hence improvement in IQ score suggested improvement in above functional aspects of *Buddhi*. No adverse reaction was found during the course of study and follow-up. By observing the results obtained, it can be concluded that *Yashtimadhu* Granules at given dose and duration indeed possesses a significant efficacy in improving *Medha* (IQ).
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